Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Ana Christina Garrido-Castro, M.D.

Concepts (133)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Neoadjuvant Therapy8202428950.740 Why?
Breast Neoplasms, Male120202130.630 Why?
Trinitrotoluene1201860.610 Why?
Breast Neoplasms142025210690.610 Why?
Receptor, erbB-25202425920.580 Why?
Aminopyridines220235760.580 Why?
Morpholines120205770.570 Why?
Class I Phosphatidylinositol 3-Kinases120209040.520 Why?
Receptors, Estrogen4202422420.410 Why?
Neoplasm Recurrence, Local6202393730.400 Why?
Molecular Targeted Therapy3202428230.370 Why?
Patient Selection1201942480.270 Why?
Immunoconjugates220259760.260 Why?
Genomics3202359250.260 Why?
Camptothecin220255980.220 Why?
Antineoplastic Combined Chemotherapy Protocols52025118580.220 Why?
Immunotherapy6202447460.200 Why?
Mammary Neoplasms, Animal120221220.190 Why?
Neoplasm Metastasis3202448820.180 Why?
Immunohistochemistry22024110300.180 Why?
Protein Kinase Inhibitors3202456910.180 Why?
Neoplasm Staging32024111960.170 Why?
Inflammatory Breast Neoplasms120211500.160 Why?
Prognosis72024298900.160 Why?
Albumins120205780.140 Why?
Paclitaxel2202317260.140 Why?
Biological Therapy120181400.130 Why?
Survival Rate32020128220.130 Why?
Lymphatic Metastasis2202128850.130 Why?
Proto-Oncogene Proteins c-akt1202424550.130 Why?
Endocrine System Diseases120182440.120 Why?
Carboplatin120187870.120 Why?
Female2320253961410.120 Why?
Neoplasms, Second Primary1202210560.120 Why?
Lupus Vasculitis, Central Nervous System12014320.110 Why?
PTEN Phosphohydrolase1202011170.110 Why?
Inositol120142150.110 Why?
Humans3220257659260.100 Why?
Antineoplastic Agents32024136310.090 Why?
Bone Marrow Cells1201824110.090 Why?
Kaplan-Meier Estimate1202065030.090 Why?
Communicable Diseases120188730.080 Why?
Cell Lineage1201825730.080 Why?
Combined Modality Therapy2202185220.080 Why?
Parietal Lobe120148590.080 Why?
Middle Aged920242230160.080 Why?
High-Throughput Nucleotide Sequencing1202036610.070 Why?
Genetic Testing1202135940.070 Why?
Aged, 80 and over22024594960.070 Why?
Treatment Outcome32024651940.070 Why?
Aged520241711630.070 Why?
Proteomics1202039060.070 Why?
Adult620242230880.060 Why?
Young Adult22024598570.060 Why?
Hematopoietic Stem Cells1201834050.060 Why?
Mutation22020301920.060 Why?
Disease Progression22020136140.060 Why?
Melanoma1202356950.060 Why?
Decision Making1201739550.050 Why?
Gene Expression Profiling1201995250.050 Why?
Biology120242930.050 Why?
Ki-67 Antigen120236280.050 Why?
Antibodies, Monoclonal1201892390.040 Why?
Biopsy2202467660.040 Why?
Phthalazines120233970.040 Why?
Drug Synergism1202417510.040 Why?
Organ Specificity1202419640.040 Why?
Signal Transduction22024235970.040 Why?
Purines120236160.040 Why?
Cell Death1202416760.040 Why?
Genetic Predisposition to Disease12021180740.040 Why?
Tumor Microenvironment2202239400.040 Why?
BRCA2 Protein120238020.040 Why?
Observer Variation1202426110.040 Why?
Retrospective Studies22024815370.040 Why?
Endocrine Glands120181010.040 Why?
Estrogens1202415280.040 Why?
BRCA1 Protein1202311550.030 Why?
Xenograft Model Antitumor Assays1202436040.030 Why?
Survival Analysis22021100860.030 Why?
Antigens, Neoplasm1202319950.030 Why?
Granulocyte Colony-Stimulating Factor120186330.030 Why?
Mice42024817820.030 Why?
Cell Line, Tumor22024170600.030 Why?
Germ-Line Mutation1202318850.030 Why?
Osteoclasts120187130.030 Why?
Lymphocytes, Tumor-Infiltrating1202011040.030 Why?
Drug Therapy, Combination1202463060.030 Why?
Cell Differentiation22024116390.030 Why?
Breast1202219500.030 Why?
Animals520241687350.030 Why?
Immunologic Factors1202115900.030 Why?
Immunocompromised Host120188650.030 Why?
Adolescent12020888110.020 Why?
Mice, Nude1201836080.020 Why?
Communicable Disease Control120188560.020 Why?
Drug Resistance, Neoplasm1202553330.020 Why?
Epigenesis, Genetic1202238160.020 Why?
Hematopoiesis1201820600.020 Why?
Quinazolines1201513660.020 Why?
Atrophy1201416290.020 Why?
Nuclear Proteins1202357820.020 Why?
Receptors, Cell Surface1201828140.020 Why?
DNA Methylation1202244240.020 Why?
Neoplasm Proteins1202035920.020 Why?
Mass Spectrometry1201521940.020 Why?
Bone Marrow1201829160.020 Why?
Multivariate Analysis12021120590.020 Why?
Consensus1201832020.020 Why?
Enzyme Inhibitors1201837160.020 Why?
Vascular Endothelial Growth Factor A1201834980.020 Why?
Proportional Hazards Models12021125290.020 Why?
CD8-Positive T-Lymphocytes1202046410.020 Why?
Temporal Lobe1201417150.020 Why?
Bone Neoplasms1201825590.020 Why?
Up-Regulation1201441300.010 Why?
Predictive Value of Tests12021154010.010 Why?
Gene Expression Regulation, Neoplastic1202086030.010 Why?
Transcription Factors12023121290.010 Why?
Macrophages1201857720.010 Why?
Male120203638150.010 Why?
Clinical Trials as Topic1201880370.010 Why?
Immunosuppressive Agents1201442130.010 Why?
Randomized Controlled Trials as Topic12018103800.010 Why?
Mice, Inbred C57BL12018223270.010 Why?
Incidence12018215130.010 Why?
Follow-Up Studies12020392280.010 Why?
Cohort Studies12020416800.010 Why?
Cognition1201470430.010 Why?
Prospective Studies12021548070.010 Why?
Time Factors12014400970.010 Why?
Neoplasms12018223400.000 Why?
Magnetic Resonance Imaging12014365470.000 Why?
Garrido-Castro's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (133)
Explore
_
Co-Authors (83)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.